Nevada Cancer Institute-Summerlin Campus — Las Vegas, Nevada

Nevada Cancer Institute-Summerlin Campus is a clinical research site located in Las Vegas, Nevada, United States 89135.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Nevada Cancer Institute-Summerlin Campus has participated in 10 clinical trials with 4 currently active.

Therapeutic areas: Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v6 and v7, Stage II Bladder Cancer AJCC v6 and v7.

Sponsors: National Cancer Institute (NCI), SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nevada Cancer Institute-Summerlin Campus?

Nevada Cancer Institute-Summerlin Campus has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nevada Cancer Institute-Summerlin Campus conducted?

Nevada Cancer Institute-Summerlin Campus has 10 clinical trials on record, with 4 currently active. Their work covers Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v6 and v7, Stage II Bladder Cancer AJCC v6 and v7.

Is Nevada Cancer Institute-Summerlin Campus accredited by Crixeo Health?

Yes — Nevada Cancer Institute-Summerlin Campus holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Nevada Cancer Institute-Summerlin Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.